NEW YORK, Aug. 4 /PRNewswire-Asia-FirstCall/ -- American
Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or
"AOBO"), a pharmaceutical company dedicated to improving health
through the development, manufacture and commercialization of a
broad range of prescription and over the counter ("OTC") products,
today announced that it plans to release second quarter 2010
financial results on Monday, August 9,
2010, before the market opens.
The Company will hold a conference call at 8:00 am ET on Monday,
August 9, to discuss its results. Listeners may access the
call by dialing 1-800-573-4842 or 1-617-224-4327 for international
callers, access code: 10613898. A webcast will also be available
through AOB's website at http://www.bioaobo.com .
A replay of the call will be available through August 16, 2010. Listeners may access the replay
by dialing 1-888-286-8010 or 1-617-801-6888 for international
callers, access code: 35043398.
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering, Inc. is a pharmaceutical
company dedicated to improving health through the development,
manufacture and commercialization of a broad range of prescription
and over the counter products.
Statements made in this press release are forward-looking and
are made pursuant to the safe harbor provisions of the Securities
Litigation Reform Act of 1995. Such statements involve risks and
uncertainties that may cause actual results to differ materially
from those set forth in these statements. The economic,
competitive, governmental, technological and other factors
identified in the Company's filings with the Securities and
Exchange Commission, including the Form 10-K for the year ended
December 31, 2010, may cause actual
results or events to differ materially from those described in the
forward looking statements in this press release. The Company
undertakes no obligation to publicly update or revise any
forward-looking statements, whether because of new information,
future events, or otherwise.
SOURCE American Oriental Bioengineering, Inc.
Copyright g. 4 PR Newswire